P. Debnath, et al.
InorganicaChimicaActa510(2020)119736
chloride with 2-(4-hydroxynaphthylazo) benzoic acid using triethyla-
mine as base under refluxing condition with (M:L = 2:1) molar ratio. In
this procedure, 2-(4-hydroxynaphthylazo) benzoic acid (0.219 g,
0.752 mmol) was dissolved in 30 mL anhydrous methanol in a round
bottom flask in presence of triethylamine base (0.152 g, 1.505 mmol)
and was refluxed on an oil bath for about 30 min with an equipped
water cooled condenser. Then, trimethyltin(IV) chloride (0.3 g,
1.5055 mmol) was then added to the reaction mixture with continuous
stirring. It was again refluxed for about 6 h and then filtered. The
precipitate containing Et3N.HCl was filtered off and the filtrate was
then collected, evaporated to dryness. The final product was washed by
hexane to get the pure deep red crystalline product. The small crys-
talline product obtained after purification was then recrystallized from
anhydrous methanol to obtain pure red crystals of the complex 2. Yield:
0.672 g, 68%; m.p.: 216–217 °C. Anal.calcd. for C23H32N2O5Sn2: C,
42.24; H, 4.93; N, 4.28%. Found: C, 42.67; H, 4.32; N, 4.13%. IR (KBr,
cm−1): 3439 ν(NH), 2923 ν(CeH str. of Sn-CH3), 1639 ν(COO)asy, 1450
ν(N]N), 1352 ν(COO)sym 1160 ν(CeO), 681 ν(Sn-C), 522 ν(Sn-O). 1H
NMR (CDCl3, 400.13 MHz) δH, Ligand skeleton: 8.43 [d, 1H, H-9,
J = 8.0 Hz], 8.28 [d, 1H, H-6, J = 7.6 Hz], 8.12 [d, 1H, H-3,
J = 8.0 Hz], 7.59 [m, 2H, H-7, H-8], 7.48[m, 2H, H-2 , H-4′], 7.37 [m,
Dualflex, Pilatus 300 K diffractometer [26] with Photon Jet micro-focus
X-ray Source while the crystals 2 and 3 were measured using a Bruker
AXS Smart APEX-II CCD diffractometer [27]. Data collection, cell re-
using CrysAlis PRO software [26] for H2L and 1. Whereas the SMART
and SAINT-PLUS [28] programs were used for 2 and 3, respectively.
The crystal structures were solved by using direct methods with the
SHELXT 2018/2 program [29]. Atomic scattering factors were taken
from the International Tables for X-ray Crystallography. Positional
parameters of non-H-atoms were refined by a full-matrix least-squares
method on F2 with anisotropic thermal parameters by using the SHELXL
2018/3 program [30]. All hydrogen atoms were placed in calculated
positions (CeH = 0.93–0.98 Å) and included as riding contributions
with isotropic displacement parameters set to 1.2–1.5 times the Ueq of
the parent atom. Despite many attempts to crystallize, the quality of
crystals used in the analysis was not very good, therefore there were
some problems with refining the structures. In structure 1, a disorder in
one of the butyl groups was observed. Thus the ellipsoids of some C
atoms in the disordered region were odd-shaped. The SIMU restraints
have been applied in the refinement and a slight improvements in shape
o ellipsoids was obtained. The disorder ratio was 0.731(9):0.269(9). In
structure 2 all attempts to model the disorder in water molecule in
order to find proper positions of hydrogen atoms failed. So, we decided
to bypass these hydrogen atoms from the model of structure during the
refinement. In addition, for 2 and ligand salt data twin refinement was
required. In 1 and 3 contribution of highly disordered solvent (pre-
sumably toluene and/or water), which could not be modeled, was re-
moved by SQUEEZE routine using PLATON [31]. For structure 1, the
three voids of about 350 Å3 each containing 59 electrons were found.
Whereas for structure 3 the one void volume was 520 Å3 and contained
125 electrons. Crystal data and structure refinement parameters are
shown in Table 1, while selected geometric parameters are collected in
1H, H-5′], 7.16 [t, 1H, H-6′,
J = 8.0 Hz], 6.67[d, 1H, H-3,
J = 10.0 Hz]; Sn-CH3Skeleton: 0.75 [s, 9H, (Sn-CH3)] 2J [119Sn-1H
(57.21 Hz)] ppm. 13C NMR (CDCl3, 100.62 MHz) δC, Ligand skeleton:
179.2 [COO], 173.7 [C-4],144.2 [C-1′], 141.8 [C-1], 134.3 [C-5′],
133.7 [C-10], 133.3 [C-3′], 132.5 [C-4ʹ], 129.1 [C-6], 128.7 [C-8],
128.4 [C-7], 127.5 [C-2′], 126.5 [C-2], 125.6 [C-5], 124.1 [C-9], 122.4
[C-6′], 116.3 [C-3]; Sn-CH3 Skeleton: −1.7 [Sn-CH3] ppm. 119Sn NMR
(CDCl3, 149.18 MHz): + 139.21 ppm.
2.2.4. Synthesis of [Bu2Sn(HL)2]2 (3)
Dibutyltin(IV) compound 3 was synthesized following analogous
procedure as in case of compound 1 where dibutyltin(IV) oxide (0.3 g,
1.20 mmol) was used instead of bis-tributyltin(IV) oxide with 2-(4-hy-
droxynaphthylazo) benzoic acid (0.704 g, 2.41 mmol) in (M:L = 1:2)
molar ratio fixed with the Dean-Stark apparatus under refluxing condi-
tion to get deep red compound 3. Yield: 0.67 g, 84%; m.p.: 211–212 °C.
Anal.calcd. for C84H80N8O12Sn2: C, 61.86; H, 4.94; N, 6.87%. Found: C,
61.73; H, 5.1; N, 6.81%. IR (KBr, cm−1): 3139 ν(NeH str.), 2921 ν(CeH
str. of Bu), 1627 ν(COO)asym, 1475 ν(N]N), 1440 ν(COO)sym 1178
ν(CeO), 675 ν(Sn-C), 501 ν(Sn-O).1H NMR (CDCl3, 400.13 MHz) δH,
Ligand skeleton: 12.5 [s, 1H, OH], 8.48 [d, 1H, H-9, J = 8.0 Hz], 8.17
[m, 2H, H-2 & H-3′], 8.04 [d, 1H, H-6, J = 8.0 Hz], 7.67 [m, 3H, H-7, H-
8 & H-4′], 7.51[t, 1H, H-5′, J = 7.6 Hz], 7.11 [t, 1H, H-6′, J = 7.6 Hz],
6.74 [d, 1H, H-3, J = 10 Hz]; Sn-nBu Skeleton: 1.95[m,2H, H-α], 1.82
[m, 2H, H-β], 1.50 [m, 2H, H-γ], 0.93 [t, 3H, H-δ] ppm. 13C NMR (CDCl3,
100.62 MHz) δC: 184.9 [COO], 176.7 [C-4],145.8 [C-1′], 135.6 [C-1],
2.4. Anti-diabetic assay
Anti-diabetic activities of compounds 1–3 and standard drug acar-
bose were screened following the 96-well microplate-based α-glucosi-
dase assay as described by Kumar et al.[32] and also using our earlier
dissolved in 20 µL DMSO (D) and Ethanol (E) and diluted to 1000 µL in
a 2 mL Eppendorf tube with sterile water (Milli-Q) and these samples
were employed for the enzyme assay. Studies of the α-glucosidase en-
zyme inhibition assay were performed in a reaction volume of 75 μL
using 96-well microplate. In this method, 25 μL each of sample solution
and α-glucosidase enzyme (0.5U) were gently mixed and pre-incubated
at 37 °C 1 °C for 10 min. Then, 25 μL of the substrate (0.5 mM, p-
nitrophenyl α-D glucopyranoside, PNPG) was added to the reaction
mixture and incubated again at 37 °C 1 °C for 30 min. After this, by
́
134.1 [C-5 ], 132.8 [C-10], 132.3 [C-3ʹ], 130.2 [C-4ʹ], 129.0 [C-6], 128.2
[C-8], 126.1 [C-7], 125.3 [C-2′], 123.9 [C-2], 123.0 [C-5], 121.3 [C-9],
114.5 [C-6′], 112.4 [C-3]; Sn-nBu Skeleton: 26.9 [C-β], 26.4 [C- γ], 21.4
[C-α], 13.6 [C-δ] ppm. 119Sn NMR (CDCl3, 149.18 MHz): −133.39 ppm.
The numbering scheme of Sn-Bu skeletal in the tributyltin(IV) and di-
butyltin(IV) complexes is shown below
adding 100 μL of 0.2 M sodium carbonate solution, the reaction was
terminated. The amount of p-nitrophenol released from PNPG (yellow
colour) was then quantified on a 96-well microplate at 405 nm using
UV visible spectrophotometer (Mustikan GO, Thermo-Scientific, Fin-
land). The α-glucosidase inhibitor drug (Acarbose, ACB) was employed
as standard reference. All reactions were performed in five replicates.
The percentage of α-glucosidase inhibition activity was calculated with
the help of the formula i.e. α-glucosidase inhibition activity
(%) = [(Control OD-Sample OD) / Control OD] x100) where Control
OD = OD of the control reaction without inhibitor-Blank OD; Sample
OD = Sample OD-Sample blank OD]. Similarly, the experiment for
dose–effect analysis of antidiabetic activity was performed using in vitro
α-glucosidase assay in a reaction volume of 75 μL using 96-well mi-
croplate as described above. A sample solution of 5, 10, 15, 20 and
25 μL (~67, 133, 266 and 333 μg/mL) were mixed with 25 μL of the α-
2.3. Crystallographic data collection and structure refinement
Single crystal X-ray diffraction data were collected by the ω-scan
technique using MoKα (λ = 0.71073 Å) radiation. The H2L salt and 1
crystals were studied at 100 K using a RIGAKU XtaLAB Synergy,
3